NST Appoints Goseong Kyu as President of the Korea Institute of Oriental Medicine

Former Dean of Kyung Hee University

Korean Medicine R&D Expert

Goseong Kyu, a professor at Kyung Hee University's College of Korean Medicine, has been appointed as the new president of the Korea Institute of Oriental Medicine. With a leader who has experience in Korean medicine research and development (R&D), new drug development, and medical innovation policy taking the helm, there is growing attention as to whether the institute will accelerate the industrialization and commercialization of Korean medicine research.

The National Research Council of Science & Technology (NST) announced on April 8 that it held its 240th temporary board meeting and appointed Professor Goseong Kyu as the president of the Korea Institute of Oriental Medicine. The new president received his letter of appointment from Kim Youngsik, Chairman of NST, on the same day and will begin his three-year term from April 9, 2026, to April 8, 2029.

Gosung Kyu, New President of Korea Institute of Oriental Medicine. Provided by National Research Council of Science and Technology (NST)

Born in 1967, President Goseong Kyu graduated from Jeonju High School, earned his bachelor's, master's, and doctorate degrees in Korean medicine from Kyung Hee University, and obtained a doctorate in medicine from Seoul National University. His combined expertise in Korean medicine, tumor biology, and public health is recognized as a significant strength.

Since joining Kyung Hee University's College of Korean Medicine as a professor in 2005, he has served as dean, vice president of the Korean Medical Association, chairman of the National New Drug Development Foundation, member of the Medical Innovation Committee, and advisory member of the National Planning Advisory Committee. He is also currently the CEO of Jaein RNP Co., Ltd., earning him a reputation for bridging academia, policy, and industry.

In particular, as he has served as chairman of the National New Drug Development Foundation since last year, there is keen interest in whether the Korea Institute of Oriental Medicine will expand its scope beyond traditional Korean medicine research to include the discovery of new drug candidates, data-driven clinical validation, and the integration of digital health technologies.

The Korea Institute of Oriental Medicine is a government-funded research institute responsible for research on herbal resources, Korean medical clinical studies, digital Korean medicine, and natural product-based new drugs. Recently, it has also been expanding research on AI-based Korean medical diagnostics and personalized treatments.

This content was produced with the assistance of AI translation services.